摘要
目的 探讨分析奥沙利铂和替吉奥联合治疗晚期胆道肿瘤疾病患者的临床效果。方法 根据2013年1月~2015年1月我院的60例晚期胆道肿瘤患者进行研究分析,将这些患者分成对照组和观察组,均有30例,观察组患者接受奥沙利铂联合替吉奥治疗。对照组患者接受奥沙利铂联合吉西他滨治疗。对两组的临床治疗效果比较分析。结果 两组OS对比差异存在统计学意义（P〈0.05）。两组TTP结果差异存在统计学意义。观察组治疗有效率为23.3%,对照组有效率为20%,结果差异无统计学意义（P〉0.05）。结论 奥沙利铂联合替吉奥有效减少患者不良反应发生状况。
Objective To investigate the clinical effect of S-1 combined with oxaliplatin and treatment of advanced biliary tract cancer patients. Methods 60 patients with advanced biliary cancer patients were chosen to research and analysis from January 2013 to 3anuary 2015 in our hospital, these patients were divided into control group and observation group, there were 30 cases of observed group of patients treated with oxaliplatin combined with s-1. The control group received oxaliplatin combined with gemcitabine in the treatment of. Comparative analysis of clinical therapeutic effect of the two groups. Results There were statistically significant differences in OS between the two groups （P〈0.05）. There were statistically significant differences between the two groups TTP. The treatment efficiency of the observation group was 23.3%. the control group was 20%, and the results were not statistically significant （P〉0.05）. Conclusion Oxaliplatin effectively reduce adverse reaction, to promote the use in the treatment of advanced tumor of binary tract.
出处
《中国继续医学教育》
2016年第26期162-163,共2页
China Continuing Medical Education
